MedTrace Logo

Safety and Performance of the Semical Adhesion Barrier Gel for Prevention of Intra-uterine Adhesion

NCT07160764 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2025-09-08

No results posted yet for this study

Summary

The aim of this study was to obtain short- and long-term performance and safety data of cross-linked hyaluronic acid-based adhesion barrier gel used to prevent intrauterine adhesion formation.

Conditions

  • Intrauterine Abnormalities in Infertility
  • Asherman Syndrome
  • Intra-uterine Adhesions
  • Postoperative Adhesion of Uterus
  • Asherman's Syndrome

Sponsors & Collaborators

  • Antalya Training and Research Hospital

    collaborator OTHER_GOV

  • Semikal Technology

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-11-01
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07160764 on ClinicalTrials.gov